(Q33868784)

29 July 2017

0 references

FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis (English)

1 reference

29 July 2017

1 reference

LingLing Pan

1

1 reference

29 July 2017

Yuan Han

2

1 reference

29 July 2017

XiaoGuang Sun

3

1 reference

29 July 2017

JianJun Liu

4

1 reference

29 July 2017

Huang Gang

5

1 reference

29 July 2017

language of work or name

1 reference

21 January 2010

1 reference

Journal of Cancer Research and Clinical Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

136

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

1007-1022

1 reference

99m Tc-sestamibi scintimammography in detection of recurrent breast cancer

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

An overview of prognostic factors for long-term survivors of breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Meta-DiSc: a software for meta-analysis of test accuracy data.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The value of FDG positron emission tomography in the management of patients with breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Conducting systematic reviews of diagnostic studies: didactic guidelines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The architecture of diagnostic research

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

MRI of the brachial plexus: a review of 51 cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Axillary lymph node metastases in breast cancer: preoperative detection with US.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Detection of local recurrence after conservative therapy for breast carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The role of diagnostic CT scanning of the brachial plexus and axilla in the follow-up of patients with breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The role of PET/CT for evaluating breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The role of FDG-PET/CT in suspected recurrence of breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Computed tomography in suspected local breast cancer recurrence.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Initial experience with FDG-PET/CT in the evaluation of breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Ultrasonographic detection of occult cancer in patients after surgical therapy for breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The use of scintimammography for detecting the recurrence of loco-regional breast cancer: histopathologically proven results

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Follow-up of women with breast cancer: comparison between MRI and FDG PET.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

The value of positron emission tomography in the follow-up for breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Prognostic impact of second cancer on the survival of early breast cancer patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

29 October 2018

Cancer statistics, 1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874488

Mammographic detection of recurrent cancer in the irradiated breast

29 October 2018

1 reference

12 December 2020

Radiographic evaluation of brachial plexopathy

1 reference

12 December 2020

Diagnosis of diseases of the supraclavicular region by use of MR imaging

1 reference

12 December 2020

Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences

1 reference

12 December 2020

Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling

1 reference

12 December 2020

[Breast cancer screening. State of the art and introduction to preventive measures]

1 reference

12 December 2020

Breast cancer recurrence after mastectomy: diagnosis with mammography and US

1 reference

12 December 2020

Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients

1 reference

12 December 2020

Contrast-enhanced MRI of the breast after limited surgery and radiation therapy

1 reference

12 December 2020

A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer

1 reference

12 December 2020

MR imaging of disorders of the brachial plexus

1 reference

12 December 2020

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

12 December 2020

The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses

1 reference

12 December 2020

[Magnetic resonance mammography in suspected tumor recurrences]

1 reference

12 December 2020

Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up

1 reference

12 December 2020

Contrast-enhanced CT: value for diagnosing local breast cancer recurrence after conservative treatment

1 reference

12 December 2020

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

12 December 2020

Value of MR mammography in the detection and exclusion of recurrent breast carcinoma

1 reference

12 December 2020

Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography

1 reference

12 December 2020

Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast

1 reference

12 December 2020

Assessment of local recurrence after breast-conserving therapy with MRI

1 reference

12 December 2020

Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancer

1 reference

12 December 2020

Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience

1 reference

12 December 2020

Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence

1 reference

12 December 2020

Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions

1 reference

12 December 2020

Doppler US with perfusion software and contrast medium injection in the early evaluation of radiofrequency in breast cancer recurrences: a prospective phase II study

1 reference

12 December 2020

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials

1 reference

12 December 2020

The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy

1 reference

12 December 2020

Recurrent disease after breast preserving therapy (BPT) and radiation therapy for breast cancer--diagnostic yield of palpation, mammography and ultrasonography

1 reference

12 December 2020

Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography

1 reference

12 December 2020

Publications on diagnostic test evaluation in family medicine journals

1 reference

12 December 2020

Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases

1 reference

12 December 2020

The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy

1 reference

12 December 2020

Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography

1 reference

12 December 2020

Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06

1 reference

12 December 2020

Prediction of the long-term survival in breast cancer patients according to the present oncological status

1 reference

12 December 2020

Role of magnetic resonance imaging in the diagnosis of recurrence after breast conserving therapy

1 reference

12 December 2020

10.1007/S00432-009-0746-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference